US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 4.860
- +0.360+8.00%
Close Jul 22 16:00 ET
173.59MMarket Cap-7053P/E (TTM)
4.950High4.409Low81.50KVolume4.560Open4.500Pre Close383.60KTurnover0.36%Turnover RatioLossP/E (Static)35.72MShares55.00052wk High-45.00P/B110.37MFloat Cap3.90052wk Low--Dividend TTM22.71MShs Float55.000Historical High--Div YieldTTM12.02%Amplitude3.900Historical Low4.706Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
FibroBiologics Stock Forum
The rest of stock continue to fall on a friday
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
FibroBiologics (Nasdaq: FBLG), a clinical-stage biotech company, has developed a novel artificial thymus organoid capable of restoring immune function in severe combined immunodeficiency (SCID) mouse models. This organoid is made from fibroblasts and thymus-derived cells and can produce mature and diverse T cells, including CD4, CD8, and regulatory T cells. The comp...
$BiomX(PHGE.US)$ $Larimar Therapeutics(LRMR.US)$ $Clene(CLNN.US)$ $Glucotrack(GCTK.US)$ $Sonnet BioTherapeutic(SONN.US)$ $FibroBiologics(FBLG.US)$ $NanoString Technologies(NSTGQ.US)$
📊⚡️📊
No comment yet